Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic During Chemotherapy: A GETUG-AFU 28 Study

NCT03101046 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03101046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic During Chemotherapy: A GETUG-AFU 28 Study
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
November 15, 2018
Completion date
December 31, 2021
Enrollment
40 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer, chemotherapy, circulating tumor cells, prostate carcinoma